RNA Origami Nanostructures for Potent and Safe Anticancer Immunotherapy

Area of Science:

• Nucleic acid nanotechnology
• RNA nanotechnology
• Immunotherapy

Background:

• Advancements in nucleic acid nanotechnology allow for programmable self-assembling nanostructures.
• Single-stranded RNA origami (RNA-OG) technology enables the creation of diverse RNA nanostructures.
• RNA nanostructures exhibit stability in biological fluids like serum and plasma.

Purpose of the Study:

• To investigate the immunostimulatory potential of RNA origami (RNA-OG).
• To evaluate the efficacy of RNA-OG in a murine model of peritoneal metastatic colon cancer.
• To compare the safety and efficacy of RNA-OG with polyinosinic/polycytidylic acid (PolyIC).

Main Methods:

• Development and application of replicable single-stranded RNA origami (RNA-OG) technology.
• Assessment of RNA-OG stability in serum/plasma.
• Evaluation of innate immune response activation, primarily through the Toll-like receptor 3 (TLR3) pathway.
• In vivo testing in a murine peritoneal metastatic colon cancer model.
• Analysis of NK- and CD8-dependent antitumor immunity and peritoneal immunosuppressive environment.

Main Results:

• RNA-OG demonstrated high stability in serum/plasma.
• RNA-OG potently stimulated innate immunity via TLR3.
• Intraperitoneal injection of RNA-OG led to significant tumor retardation or regression in mice.
• RNA-OG activated NK and CD8 T cells, enhancing antitumor immunity.
• RNA-OG treatment did not induce high levels of type-I interferons or apparent toxicity, unlike PolyIC.

Conclusions:

• RNA-OG functions as a potent Toll-like receptor 3 (TLR3) agonist.
• RNA-OG exhibits potential as a safe and effective agent for cancer immunotherapy.
• RNA-OG technology offers a promising new avenue for developing cancer therapeutics.